Explain aspirin related to bvsc

Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Searching the Web

aspirin pharmacology BVSc veterinary uses doses cats dogs species sensitivity

Loading Image
Loading Image
Loading Image
I have all the information needed. Here is the full BVSc-oriented explanation of Aspirin.

Aspirin (Acetylsalicylic Acid) - BVSc Pharmacology

Drug Classification

Aspirin belongs to the Salicylate group of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs). It is the prototype and most studied member of this class.
  • Chemical name: Acetylsalicylic acid (ASA)
  • Drug class: NSAID - Salicylate derivative
  • Nature: Weak organic acid

Mechanism of Action

Aspirin works by irreversibly inhibiting cyclooxygenase (COX) enzymes through acetylation.

The Arachidonic Acid Pathway:

  1. Cell membrane phospholipids are cleaved by phospholipase A2 to release arachidonic acid
  2. COX-1 converts arachidonic acid to Prostaglandin H2 (PGH2)
  3. PGH2 is further converted to:
    • Thromboxane A2 (TXA2) - promotes platelet aggregation and vasoconstriction
    • Prostacyclin (PGI2) - inhibits platelet aggregation, causes vasodilation
    • Prostaglandins (PGE2, PGF2) - mediate inflammation, pain, fever

How Aspirin Acts:

Aspirin acetylates a serine residue on the active site of COX-1 (and to a lesser extent COX-2), thereby irreversibly inactivating the enzyme. This is a key distinction - while other NSAIDs are reversible, competitive inhibitors, aspirin's inhibition is permanent and irreversible.
Aspirin acetylates cyclooxygenase, converting it to an inactive acetylated form while itself becoming salicylic acid
Figure: Aspirin transfers its acetyl group to COX, inactivating it, and is itself converted to salicylic acid - Lippincott Illustrated Reviews: Pharmacology

Pharmacological Actions (The "3 A's")

ActionMechanismDose Required
AnalgesicReduces PGE2, which sensitizes nerve endings to bradykinin/histamineLow-moderate dose
AntipyreticInhibits PGE2 synthesis in hypothalamus, resets thermostatLow-moderate dose
Anti-inflammatoryReduces prostaglandin and thromboxane production at inflamed sitesHigh dose only
AntiplateletIrreversibly inhibits TXA2 synthesis in plateletsVery low dose (75-325 mg)
Key BVSc point: Anti-inflammatory activity requires high doses (equivalent to 12-20 tablets/day in humans), while analgesia and antipyresis occur at lower doses. - Lippincott Illustrated Reviews: Pharmacology

Pharmacokinetics (ADME)

ParameterDetail
AbsorptionOral; passive diffusion; well absorbed from GI tract
DistributionWidely distributed; crosses placenta and blood-brain barrier
MetabolismRapidly hydrolyzed to salicylic acid in liver and plasma by esterases
ExcretionUrine; rate depends on urinary pH (alkaline urine increases excretion)
Half-life (aspirin)15-20 minutes (very short - quickly converted to salicylate)
Half-life (salicylate)3-12 hours (dose-dependent, increases at high doses due to enzyme saturation)

Veterinary Uses (BVSc Focus)

In Dogs:

  • Treatment of mild to moderate pain (arthritis, musculoskeletal pain)
  • Anti-inflammatory use in chronic joint disease
  • Antithrombotic therapy in conditions like heartworm disease, DIC
  • Dose: typically 10-25 mg/kg every 12 hours (with food)

In Cats - SPECIAL SPECIES SENSITIVITY:

Cats are highly sensitive to aspirin toxicity due to a deficiency in glucuronyl transferase enzyme, which impairs hepatic metabolism of salicylates. Cats cannot metabolize aspirin efficiently.
  • The dosing interval in cats is every 48-72 hours (compared to every 12 hours in dogs)
  • Use is very restricted; safer alternatives are preferred
  • Cats can develop severe toxicity even at "therapeutic" doses

Other Species:

  • Horses: Used for anti-inflammatory and antithrombotic purposes
  • Cattle: Less common; GI irritation risk

Adverse Effects

Common:

  • GI irritation - dyspepsia, gastritis, peptic ulceration (due to inhibition of cytoprotective prostaglandins - PGE2 and PGI2 in the gastric mucosa)
  • Prolonged bleeding time - due to irreversible platelet COX inhibition; effects last for the entire platelet lifespan (~7-10 days)
  • Renal effects - at high doses; reduces renal prostaglandins important for blood flow

Serious/Toxic Effects:

Acute Salicylate Toxicity (Overdose):
  1. Initial: Respiratory alkalosis - direct stimulation of the respiratory center in the medulla causes hyperventilation
  2. Later: Metabolic acidosis - uncoupling of oxidative phosphorylation, inhibition of Krebs cycle, accumulation of pyruvate and lactate
  3. Fatal doses: as low as 3 g in children (relevant to small animals proportionally)
Chronic Salicylism (at doses ~100 mg/kg/day):
  • Tinnitus (ringing in ears)
  • Headache, dizziness
  • Mental confusion, drowsiness
  • Nausea, vomiting, diarrhea
  • Can progress to convulsions and coma
Reye's Syndrome: In young animals/children given aspirin during viral infections - rare but serious hepatic encephalopathy. Aspirin should be avoided in young animals with suspected viral illness.
Analgesic Nephropathy: Long-term use with acetaminophen can cause tubulointerstitial nephritis with renal papillary necrosis. - Robbins & Kumar Basic Pathology

Drug Interactions

Interacting DrugEffect
Anticoagulants (heparin, warfarin)Increased bleeding risk
Other NSAIDs (ibuprofen)Ibuprofen taken 2 hours before aspirin can block aspirin's antiplatelet effect by competing at the COX active site
MethotrexateIncreased methotrexate toxicity
ProbenecidAspirin reduces uricosuric effect
CorticosteroidsIncreased GI ulceration risk

Contraindications

  • Known aspirin hypersensitivity (can cause bronchospasm)
  • Active GI ulceration or bleeding
  • Bleeding disorders / coagulopathies
  • Cats - with extreme caution only
  • Young animals with viral infections (Reye's syndrome risk)
  • Renal or hepatic insufficiency
  • Third trimester pregnancy (premature closure of ductus arteriosus)

Aspirin Resistance

All forms of treatment failure with aspirin are collectively called "aspirin resistance," but true pharmacological resistance is rare. Pseudo-resistance - reflecting delayed and reduced drug absorption - is more common (e.g., with enteric-coated formulations). - Goodman & Gilman's Pharmacological Basis of Therapeutics

Summary - Key BVSc Exam Points

  1. Aspirin = irreversible COX inhibitor (unique among NSAIDs)
  2. Acts by acetylating serine on COX active site
  3. Triple action: analgesic, antipyretic, anti-inflammatory (+ antiplatelet at low dose)
  4. Anti-inflammatory requires high doses; analgesia/antipyresis at lower doses
  5. Cats are highly sensitive - deficient glucuronyl transferase = slow metabolism = narrow safety margin
  6. Antiplatelet effect lasts 7-10 days (platelet lifespan) - irreversible effect
  7. Toxicity sequence: respiratory alkalosis first, then metabolic acidosis
  8. Chronic toxicity = salicylism (tinnitus, confusion, GI bleeding)
  9. Avoid in viral infections in young animals (Reye's syndrome)
  10. Ibuprofen can antagonize aspirin's antiplatelet effect if given 2 hours before aspirin

Sources: Lippincott Illustrated Reviews: Pharmacology; Robbins & Kumar Basic Pathology; Goodman & Gilman's The Pharmacological Basis of Therapeutics; Katzung's Basic and Clinical Pharmacology
This is a shared conversation. Sign in to Orris to start your own chat.